Pfizer announced the introduction of 3 new oncology biosimilars to the US market at a substantially discounted price.
FDA approval decision expected in the second quarter of 2020.
Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
Approximately 1 in 8 women living in the United States will develop an invasive form of breast cancer at some point in her life
Prostate cancer is the second most common cancer in men after skin cancer.
Various factors can affect a patient’s survival rate.
Why pancreatic cancer death rates are still so high.
A look at one of the most common forms of skin cancer.
Treating cancer is costly enough, but the side effects also tax the economic system.
A surprising look at glucocorticoids and their role in oncology care.